Samsung Biologics
207940.KS
$573.85
Share price
-0.13%
Change (1 day)
-4.28%
Change (1 year)
Categories
P/S ratio for Samsung Biologics (207940.KS)
P/S ratio as of April 2024 (TTM): 14.6
According to Samsung Biologics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 14.617. At the end of 2023 the company had a P/S ratio of 14.9.
P/S ratio history for Samsung Biologics from 2017 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 14.9 | -25.68% |
| 2022 | 20.0 | -46.21% |
| 2021 | 37.3 | -25.45% |
| 2020 | 50.0 | 21.53% |
| 2019 | 41.1 | -12.62% |
| 2018 | 47.1 | -14.13% |
| 2017 | 54.8 |